211
Views
1
CrossRef citations to date
0
Altmetric
EDITORIAL

Antihypertensive therapy and cancer risks?

, , &
Pages 127-128 | Published online: 20 May 2011

References

  • Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood-pressure: A risk factor for cancer mortality? Lancet. 1975;1:1051–1056.
  • Raynor WJ Jr, Shekelle RB, Rossof AH, Maliza C, Paul O. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol. 1981;113: 371–377.
  • Khaw KT, Barrett-Connor E. Systolic blood pressure and cancer mortality in an elderly population. Am J Epidemiol. 1984; 120:550–558.
  • Goldbourt U, Holtzman E, Yaari S, Cohen L, Katz L, Neufeld HN. Elevated systolic blood pressure as a predictor of long-term cancer mortality: Analysis by site and histologic subtype in 10,000 middle-aged and elderly men. J Natl Cancer Inst. 1986;77:63–70.
  • Wannamethee G, Shaper AG. Blood pressure and cancer in middle-aged British men. Int J Epidemiol. 1996;25:22–31.
  • Hamet P. Cancer and hypertension. An unresolved issue. Hypertension. 1996;28:321–324.
  • Hedner T, Hansson L, Jern S. Is hypertension a risk factor for cancer? Blood Press. 1997;6:132–133.
  • Rosengren A, Himmelmann A, Wilhelmsen L, Branehög I, Wedel H. Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens. 1998;16: 933–940.
  • Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Human Hypertens. 2005;19:373–379.
  • Kjeldsen SE, Hedner T, Oparil S, Narkiewicz K. Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports. Blood Press. 2010;19:271–272.
  • Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J, Dahlöf B, . Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: A 5-year, prospective, randomized, controlled trial. Lancet. 2001;358:539–544.
  • Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, . Antihypertensive drugs and risk of cancer: Network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials. Lancet Oncol. 2010;Nov 29. [Epub ahead of print].
  • Hedner T, Oparil S, Narkiewicz K, Kjeldsen SE. The J-curve phenomenon revisited. Blood Press. 2009;18:168–170.
  • Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11:627–636.
  • The Boston collaborative drug surveillance program. Reserpine and breast cancer. Lancet. 1974;304:669–671.
  • Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet. 1974;304:675–677.
  • Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J. 2001; 22:1343–1352.
  • Marchner IC, Simes RJ, Keech A. Biases in the identification of risk factor thresholds and J-curves. Am J Epidemiol. 2007; 166:824–831.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.